THE PROGNOSTIC/PREDICTIVE ROLE OF IDH1 GENE MUTATIONS IN PATIENTS TREATED FOR RECURRENT GLIOMA

被引:0
|
作者
Lv, S. [1 ,2 ]
Sadones, J. [1 ,2 ]
Teugels, E. [1 ,2 ]
Huylebrouck, M. [1 ,2 ]
De Witte, O. [3 ]
Salmon, I. [4 ]
Michotte, A. [5 ]
De Greve, J. [1 ,2 ]
Neyns, B. [1 ,2 ]
机构
[1] Vrije Univ Brussel, Mol Oncol Lab, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Med Oncol, UZ Brussel, Brussels, Belgium
[3] ULB Erasme, Dept Neurosurg, Brussels, Belgium
[4] ULB Erasme, Dept Pathol, Brussels, Belgium
[5] Vrije Univ Brussel, Dept Pathol, UZ Brussel, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:31 / 32
页数:2
相关论文
共 50 条
  • [41] Association of IDH1 mutation with survival of glioma patients in Indonesia
    Malueka, R. G.
    Dwianingsih, E. K.
    Bayuangga, H. F.
    Argo, I. W.
    Donurizki, A. D.
    Shaleh, S.
    Wicaksono, A. S.
    Dananjoyo, K.
    Asmedi, A.
    Hartanto, R. A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [42] IDH1 and IDH2 Mutations in Chondrosarcomas
    Nafa, K.
    Agaram, N. P.
    Borsu, L.
    Schwartz, G.
    Healey, J.
    Ladanyi, M.
    Hameed, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 700
  • [43] Contrast enhancement as a prognostic factor in IDH1/2 mutant glioma.
    Suchorska, Bogdana
    Schueller, Ulrich
    Biczok, Annamaria
    Kreth, Friedrich Wilhelm
    Lenski, Markus
    Albert, Nathalie Lisa
    Giese, Armin
    Ertl-Wagner, Birgit
    Ingrisch, Michael
    Tonn, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Differential Prognostic Impact of IDH1 and IDH2 Mutations in Chronic Myelomonocytic Leukemia
    Walsh, Connor M.
    Hunter, Anthony
    Lasho, Terra
    Finke, Christy
    Komrokji, Rami S.
    Shah, Mithun V.
    Tefferi, Ayalew
    Mangaonkar, Abhishek A.
    Howard, Matthew T.
    Gangat, Naseema
    Al-Kali, Aref
    Al Ali, Najla
    Padron, Eric
    Patnaik, Mrinal M.
    BLOOD, 2021, 138 : 3684 - +
  • [45] Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia
    Connor Walsh
    Anthony Hunter
    Terra Lasho
    Christy Finke
    Rhett Ketterling
    Rami Komrokji
    Ayalew Tefferi
    Abhishek Mangaonkar
    Matthew Howard
    Naseema Gangat
    Aref Al-Kali
    Najla Al Ali
    Eric Padron
    Mrinal M. Patnaik
    Leukemia, 2022, 36 : 1693 - 1696
  • [46] Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia
    Walsh, Connor
    Hunter, Anthony
    Lasho, Terra
    Finke, Christy
    Ketterling, Rhett
    Komrokji, Rami
    Tefferi, Ayalew
    Mangaonkar, Abhishek
    Howard, Matthew
    Gangat, Naseema
    Al-Kali, Aref
    Ali, Najla Al
    Padron, Eric
    Patnaik, Mrinal M.
    LEUKEMIA, 2022, 36 (06) : 1693 - 1696
  • [47] TRACKINGTERT PROMOTER AND IDH1 MUTATIONS IN LIQUID BIOPSIES - SUITABLE BIOMARKERS FOR DISEASE MONITORING IN GLIOMA PATIENTS?
    Bruckner, K.
    Madlener, S.
    Lang, A.
    Kiesel, B.
    Furtner-Srajer, J.
    Hainfellner, J.
    Haberler, C.
    Spiegl-Kreinecker, S.
    Dorfer, C.
    Slavc, I
    Gojo, J.
    Rossler, K.
    Lotsch-Gojo, D.
    NEURO-ONCOLOGY, 2022, 24
  • [48] Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients
    Bujko, Mateusz
    Kober, Paulina
    Matyja, Ewa
    Nauman, Pawel
    Dyttus-Cebulok, Katarzyna
    Czeremszynska, Beata
    Bonicki, Wieslaw
    Siedlecki, Janusz A.
    MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (03) : 163 - 169
  • [49] Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients
    Mateusz Bujko
    Paulina Kober
    Ewa Matyja
    Paweł Nauman
    Katarzyna Dyttus-Cebulok
    Beata Czeremszyńska
    Wiesław Bonicki
    Janusz A. Siedlecki
    Molecular Diagnosis & Therapy, 2010, 14 : 163 - 169
  • [50] IDH1 and IDH2 mutations in Bulgarian patients with glial tumours
    Goranova, T.
    Stancheva, G.
    Mitkova, A.
    Kaneva, R.
    Poptodorov, G.
    Velinov, N.
    Mitev, V.
    Gabrovsky, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 224 - 225